IEEE SA VOICE

This episode offers a special twist to the podcast series as we delve into the world of sports and health trackers for athletes in court and field-based sports. There are groups of technologies that are used both on and around the athlete to enhance performance and keep the athlete’s condition at top level. You will hear about the latest IEEE SA project, which aims to standardize key elements in the use of these technologies for all athletes worldwide.

How old are we becoming? The global aging population is outpacing the new generation quickly. In this episode with Dr. Elizabeth Baker, we discuss the many emerging techno solutions to address the needs of a healthy and assisted living aging population that is highly diverse from demographics to geographics. Find out what design principles can be deployed by technologists that can meet the demand for accessibility and feasibility. What will support trust in the use of these technologies while preserving dignity for the aging at home?

Skin health, wound care and management are critical concerns for caregivers, long-term facility staff, and patients. Most often, damage to skin has not been detected until issues have already progressed. Dr. Sanna Gaspard, CEO and Founder of Rubitection, shares how the latest in RPM innovations offers a non-invasive, on-demand monitoring capability to improve patient outcomes with treatment, care, and prevention.

Security and protection of personal data are core tenants in driving trust in the use of remote devices and technologies for monitoring or delivering virtual care. As healthcare intersects more with consumer wellness trends, the vulnerabilities and threats to security and privacy are even more amplified. Nakia Grayson and Ronald Pulivarti from the National Cybersecurity Center of Excellence (NCCoE) at NIST, share the latest trends and efforts on how the industry is educating and offering practical guides to safeguarding the telehealth experience.

Patients in developing regions are most often the most underserved populations whereby chronic conditions are left unchecked as a result of inaccessibility to health care, facilities, or tools. IEEE Student Member, Pramuka Sooriyapatbandige, shares how his research team is looking to mitigate the issue of accessibility with a simple, yet multi-purpose RPM tool that can be utilized, accessible, and feasible for patients in developing regions.

How can we take physical therapy (PT) to the next level using real-world data from tools and devices without having to leave the home? Josh Rabinowitz, Co-Founder & CEO at Articulate Labs, joins our host, Maria Palombini, in a discussion on a new class of RPM devices that are enabling a viable option for remote patients who do not have access to a facility, but can still rehabilitate with more data and insights to improve their outcomes with or without a certified PT therapist at their side.

With the focus on accuracy, ethics, and bias in AI algorithms, we cannot lose sight of the need for more validated data. With hard-hitting insights and references, is the right question being asked: is AI good for medicine or is medicine right for AI? Dr. Dimitrios Kalogeropoulos, Senior Independent Consultant for organizations like the World Health Organization (WHO) and the United Nations International Children's Emergency Fund (UNICEF), looks to the data for answers with our host, Maria Palombini.

The time has come to unleash the value of unstructured data. Artificial Intelligence (AI) and Machine Learning (ML) afford those opportunities across the healthcare domain, however, AI and ML must be demystified and we need to embrace the value of Natural Language Processing (NLP) in daily operating systems. Alexandra Ehrlich, Principal Health Innovation Scientist at Oracle, and our host, Maria Palombini, discuss how AI and ML hold great opportunities for healthcare, but we can't lose sight of the challenge with bias permeating throughout accessible healthcare data.

RNA splicing is at the forefront of providing insights into diseases that are linked back to RNA errors. Dr. Maria Luisa Pineda, CEO & Co-Founder at Envisagenics, explains how AI, HPC (high-performance computing), and genetic data can provide the insights needed for targeted drug discovery in oncology and other genetic conditions faster and more accurately than ever.

Can Artificial Intelligence (AI) and Machine Learning (ML) support fairness, personalization, and inclusiveness to chip away at the epidemic of healthcare inequity, or will it further create more inequity in the healthcare system?

What can an emerging Latin American region teach us when it comes to cyber risk management in the digital healthcare transformation? Learn how COVID-19 made it more appealing for hackers to breach labs, healthcare systems, and any repository of patient health data and research.

Can connected healthcare be a risky business for you, the patient, and every stakeholder involved? Learn how we need to better strategize planning and response to cyber vulnerabilities in the healthcare ecosystem.